advertisement
Journal of Ocular Pharmacology and Therapeutics 15
Showing records 1 to 15 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Inoue K
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358
100284 Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study
Kutlutürk G
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 287-293
100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Ghosn C
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318
100284 Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study
Altan C
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 287-293
100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Shiokawa M
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358
100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Rajagopalan L; Ugarte S
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318
100284 Effects of Topical Antiglaucomatous Medications on Conjunctival Thickness: A Prospective Anterior Segment Optical Coherence Tomography Study
Yasar T
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 287-293
100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Kunimatsu-Sanuki S
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358
100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Mistry S
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318
100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Nozaki N; Shimizu K
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358
100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Orilla W; Goodkin ML
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318
100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Ishida K
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358
100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Robinson MR
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318
100698 One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
Tomita G
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 354-358
100357 Intraocular Pressure-Lowering Efficacy of a Sustained-Release Bimatoprost Implant in Dog Eyes Pretreated with Selective Laser Trabeculoplasty
Engles M; Dibas M
Journal of Ocular Pharmacology and Therapeutics 2022; 38: 311-318